Stocks in play: Knight Therapeutics Inc.
Reported financial results for its third quarter ended September 30, 2023. All currency amounts are in thousands except for share and per share amounts. Revenues were $81,500, an increase of $9,219 or 13% over the same period in prior-year. Net income was $9,588, compared to $1,591 in the same period in the prior year. Knight Therapeutics Inc. shares T.GUD are trading up $0.14 at $4.92.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.